160 related articles for article (PubMed ID: 1975594)
1. Elevated levels of CD4 antigen in sera of human immunodeficiency virus-infected populations.
Reddy MM; Vodian M; Grieco MH
J Clin Microbiol; 1990 Aug; 28(8):1744-6. PubMed ID: 1975594
[TBL] [Abstract][Full Text] [Related]
2. Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.
Reddy MM; Lange M; Grieco MH
J Clin Microbiol; 1989 Feb; 27(2):257-60. PubMed ID: 2492539
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of soluble CD54 (ICAM-1) in human immunodeficiency virus infection.
Reddy MM; Grieco MH
J Clin Lab Anal; 1993; 7(5):269-72. PubMed ID: 8105044
[TBL] [Abstract][Full Text] [Related]
4. Studies on cell-mediated immune defects to Epstein-Barr virus and cytomegalovirus in HIV-related disorders.
Sirianni MC; Ragona G; Soddu S; Cuomo L; Aiuti F
Ann N Y Acad Sci; 1987; 511():385-9. PubMed ID: 2830827
[No Abstract] [Full Text] [Related]
5. Elevated levels of circulating immune complexes in human immunodeficiency virus infection.
Reddy MM; Grieco MH
J Clin Lab Anal; 1990; 4(2):95-8. PubMed ID: 2313475
[TBL] [Abstract][Full Text] [Related]
6. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
7. CD4+ lymphocyte function with early human immunodeficiency virus infection.
Gurley RJ; Ikeuchi K; Byrn RA; Anderson K; Groopman JE
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1993-7. PubMed ID: 2564677
[TBL] [Abstract][Full Text] [Related]
8. Quantitative changes in T helper inducer (CD4+ CD45RA-), T suppressor inducer (CD4+ CD45RA+), T suppressor (CD8+ CD11b+), and T cytotoxic (CD8+ CD11b-) subsets in human immunodeficiency virus infection.
Reddy MM; Grieco MH
J Clin Lab Anal; 1991; 5(2):96-100. PubMed ID: 2023064
[TBL] [Abstract][Full Text] [Related]
9. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels in sera of patients with HIV infection.
Reddy MM; Grieco MH
Int J STD AIDS; 1991; 2(2):128-32. PubMed ID: 2043705
[TBL] [Abstract][Full Text] [Related]
11. Persistent immune complexes and abnormal CD4/CD8 ratios in HIV infection.
Roy S; Morrow WJ; Christian C; Khayam-Bashi H; Busch MP; McCarthy R; Rodgers RP; Vyas GN
J Acquir Immune Defic Syndr (1988); 1990; 3(2):134-8. PubMed ID: 1967308
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1.
Krowka J; Stites D; Debs R; Larsen C; Fedor J; Brunette E; Düzgünes N
J Immunol; 1990 Apr; 144(7):2535-40. PubMed ID: 1969450
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-1 disease progression in hemophiliacs.
Becherer PR; Smiley ML; Matthews TJ; Weinhold KJ; McMillan CW; White GC
Am J Hematol; 1990 Jul; 34(3):204-9. PubMed ID: 2163586
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection.
Tóth FD; Szabó B; Ujhelyi E; Pálóczi K; Horváth A; Füst G; Kiss J; Bánhegyi D; Hollán SR
AIDS; 1991 Mar; 5(3):263-8. PubMed ID: 1676275
[TBL] [Abstract][Full Text] [Related]
17. The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection.
Jacobson DL; McCutchan JA; Spechko PL; Abramson I; Smith RS; Bartok A; Boss GR; Durand D; Bozzette SA; Spector SA
J Infect Dis; 1991 Feb; 163(2):240-6. PubMed ID: 1671053
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against CD4- and CD8-positive T lymphocytes in HIV-infected hemophilia patients.
Daniel V; Weimer R; Schimpf K; Opelz G
Vox Sang; 1989; 57(3):172-6. PubMed ID: 2575824
[TBL] [Abstract][Full Text] [Related]
19. Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men.
Margalith M; Sarov B; Sarov I; Rinaldo C; Detels R; Phair J; Kaslow R; Ginsberg H; Saah A
AIDS Res Hum Retroviruses; 1990 May; 6(5):607-16. PubMed ID: 2193673
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antibody responses to Epstein-Barr virus in HIV-infected homosexual men.
Rahman MA; Kingsley LA; Breinig MK; Ho M; Armstrong JA; Atchison RW; Lyter DW; Rinaldo CR
J Infect Dis; 1989 Mar; 159(3):472-9. PubMed ID: 2536790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
